in-PharmaTechnologist presents its latest round up movements in the pharma sector, including CytRx bolstering its manufacturing expertise and KV preparing its management as it strives to resume distribution.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Takeda, Aquapharm and Cannabis Science.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at West Pharmaceutical Services, Catalent and Kforce Clinical Research.
World Courier has GxP compliant status for its whole distribution network, covering more than 140 offices in 50 countries, which it believes no other business in the sector has achieved on such a large scale.
Sanofi-Aventis plans to participate with a Russian state-owned corporation in a project to attract innovative drug manufacturers to the country, using its insulin facility as a pilot initiative.
The recent wave of M&A will lead to manufacturing over-capacity at pharma companies but only a small number of these sites will be sold to CMOs, in part because of the facilities’ suboptimal locations, according to a report.
The drug industry must “fundamentally change” how it sells products and make greater use of advanced analytics to measure performance, according to a report by Deloitte Consulting.
A five-day international anti-counterfeiting operation involving regulators, police and customs officials from 24 countries has resulted in the seizure of 167,000 counterfeit pills.
Just weeks after completing its billion dollar Wyeth takeover, US drug giant Pfizer has floated the idea of entering Japan’s $5.8bn (€3.9bn)-a-year generic drugs market in 2011 in a bid to further diversify its revenue streams.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Patheon, Pharmarama and Omnia Biologics.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Xoma and Watson Pharmaceuticals, plus a new role for Fred Hasaan.
It is “legislative madness” to allow reimportation in the US, according to the chair of EAASM who spoke at AAPS about Europe’s “porous supply chain” and how it could affect the standard of medicines in the States.
Boehringer Ingelheim looks set for a significant windfall with results from Phase III trials indicating that its drug flibanserin can boost sexual desire in women, raising the prospect of a female equivalent to Pfizer’s Viagra.
US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.
Regulatory enforcement efforts to tackle counterfeit and substandard APIs are in disarray, according to Guy Villax, CEO of Hovione, who spoke at AAPS about the scale of the problem.
Pharma’s increasing collaboration and budget cuts have made hosted software more attractive to companies, according to Symyx which has made its lab notebook available on this platform.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including multiple appointments at Almac and a new chairman at TranScrip Partners.
AAPS 2009 has drawn to a close but over the three days numerous trends and debates emerged, including the strategies CROs are using in the downturn, and we take a look at these in our conference round up.
Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Sanofi-Aventis, RXi Pharmaceuticals and Vivus.
The ICH says it made progress on its S9 guideline on non-clinical data requirement for late-stage cancer treatments at its most recent steering committee meeting in Missouri, US.
Outsourcing-Pharma presents its latest round up of movements in the pharmaceutical outsourcing sector, including appointments at PharmaNet, Kendle and INC Research.
US contract services firm Catalent has launched a new test service capable of detecting trace amounts of the toxic chemical melamine in pharmaceuticals.
US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark.
Pfizer and Nigerian authorities want Trovan compensation claimants to provide DNA samples to confirm their identity, according to former Nigerian Supreme court justice Abubakar Wali.
in-PharmaTechnologist presents its latest roundup of movements in the pharma sector, including appointments at Intrexon, Cephalon, NeoPharma and Chelsea Therapeutics.
Good news for Human Genome Sciences (HGS) as development partner GSK reports Ph III data showing that their co-owned lupus treatment Benlysta (belimumab) is effective.
Early-stage CDC research suggests that the anti-inflammatory properties of cholesterol-busting statin drugs can help mitigate the impact of flu infection.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Synteract, Quintiles, Quanticate and ClinOps.
Novavax says its new Indian vaccine plant will be operational in four months with sufficient capacity to help meet local demand for seasonal influenza vaccines.
Late last week Ecuador’s government announced plans to sidestep patents on more than 2,000 drugs, enabling them to produced local or imported as “generics”
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Hospira, PTI, Migenix and Shrink Nanotechnologies.
Outsourcing-Pharma presents its latest round of movements in the pharma outsourcing sector, including appointments at WuXi PharmaTech, Sundia, CMC Biologics and Xoma.
IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.
Kimberly-Clark Professional has launched Kimtech Pure A5 cleanroom coveralls, for sterile and non-sterile environments, to provide an affordable way to reduce the risk of contamination.
The FDA has warned consumers about the spread of counterfeit H1N1 treatments after the agency bought products advertised as Tamiflu (oseltamivir) that contained none of the active ingredient.
